Comments
Commented by Fabian Lorenz on August 27th, 2025 | 07:20 CEST
Quick 30% return possible? Novo Nordisk, D-Wave, and NetraMark shares!
Three completely different companies, but all with return potential: AI specialist NetraMark is on the verge of a technical breakout. NetraAI has outperformed ChatGPT and DeepSeek and is gaining more customers. If the breakout occurs, the stock could quickly move toward the analyst price target, representing a potential gain of around 30%. At Novo Nordisk, last week's price gains have almost been lost again. Wegovy's strong market entry in South Korea caused only brief jubilation. Now, competition from Eli Lilly is dampening the mood. At D-Wave, the stock could soon be heading toward new highs again. The Company plans to accelerate its growth in Asia, and new momentum for the stock is expected in September.
Read
Commented by Armin Schulz on August 27th, 2025 | 07:15 CEST
Benefit from the hydrogen boom: The most promising developments at Nel ASA, dynaCERT, and Daimler Truck
The hydrogen market is booming! A groundbreaking efficiency record in electrolysis is revolutionizing production costs. At the same time, the world's first commercial hydrogen flight connection is launching, proving the technology's suitability for everyday use. This boom is confirmed by a European hydrogen auction, which underscores the immense competitiveness of green hydrogen with record results. These three powerful impulses are now also driving the established players. The developments at Nel ASA, dynaCERT, and Daimler Truck are particularly noteworthy.
Read
Commented by André Will-Laudien on August 27th, 2025 | 07:10 CEST
Let off some steam! Caution advised for DroneShield, RENK, and Hensoldt - but opportunities at Pasinex
The stock market is entering a correction phase. For overheated stocks in the high-tech and defense sectors, this is a welcome opportunity to let off some steam. Now it is important to put the long-term prospects into perspective against the short-term hysteria. Doing so reveals where it may be worth buying after a correction. The charts are only just starting to rise, and a stronger correction should follow. In this context, the zinc projects of Pasinex Resources appear to be particularly attractive. As always, a balanced portfolio protects against unpleasant surprises. We present a few ideas.
Read
Commented by Armin Schulz on August 27th, 2025 | 07:05 CEST
China's leverage: Why Rheinmetall is struggling, European Lithium is benefiting, and BYD remains confident
The next wave of global conflicts will not be fought with weapons, but with export licenses. At the heart of this geopolitical struggle are critical metals without which no high-tech weapon, electric vehicle, or wind turbine can function. China's recent tightening of export restrictions has exposed the West's brutal dependency, forcing governments and corporations alike to rapidly rethink and realign their supply chains. While some companies are fighting to secure their supply chains, others are consolidating their sources or celebrating their monopolistic position. Three companies exemplify this dichotomy: the recently pressured defense giant Rheinmetall, the rare earth and lithium beneficiary European Lithium, and the Chinese giant BYD.
Read
Commented by Fabian Lorenz on August 27th, 2025 | 07:00 CEST
TAKEOVER rally and analyst reactions! Puma, CTS Eventim, AJN Resources!
Gold hopes, concert frustration, and takeover speculation—three exciting stories are currently moving the stock market. AJN Resources is starting the next phase of exploration and hopes to find millions of ounces of gold in Ethiopia. To this end, it has a strong partner on board. CTS Eventim shocks investors with weak figures, but analysts remain surprisingly calm. Is the stock now a buy? And at Puma, the possible exit of the Pinault family is causing the biggest jump in the share price in two decades. Is the cult brand facing a takeover from China? Analysts remain skeptical.
Read
Commented by André Will-Laudien on August 26th, 2025 | 07:20 CEST
Big moves! Buying frenzy at Novo Nordisk and PanGenomic Health, Valneva left behind
Things are moving again in the biotech sector! While Novo Nordisk appears to have finally found its footing after three profit warnings, PanGenomic Health continues its upward trend. Since launching its new business model in May, the stock has staged a phenomenal rally of over 1,000%. Meanwhile, Valneva faces a major setback as the US Food and Drug Administration (FDA) has halted approval of the chikungunya vaccine Ixchiq due to severe side effects. This comes as a shock to investors, who are now waiting for the Company to provide further explanations. The stock market has reacted with a sharp drop in the share price. How can investors benefit from the current situation?
Read
Commented by Stefan Feulner on August 26th, 2025 | 07:15 CEST
Freeport-McMoRan, Desert Gold Ventures, Rio Tinto – Investing in the future
What happens after Jackson Hole? Following Federal Reserve Chairman Jerome Powell's speech, which boosted the markets with the prospect of possible interest rate cuts later this year, Nvidia's earnings report on Wednesday will take center stage this week. Any disappointment could cause recent gains to vanish into thin air. Meanwhile, the price of gold remains stable and, after a brief sideways movement, could take off to new heights.
Read
Commented by Armin Schulz on August 26th, 2025 | 07:10 CEST
The blueprint for AI-driven drug discovery: How Evotec, NetraMark Holdings, and BioNTech are leveraging new opportunities
The pharmaceutical industry is undergoing a revolution. Artificial intelligence is reducing drug discovery times from years to months and dramatically increasing hit rates. Data-driven predictions and virtual simulations are increasingly replacing costly trial-and-error approaches. This technological leap is already generating concrete successes and massive competitive advantages for pioneers who implemented their digitalization strategies early on. Most recently, an AI-designed drug advanced to clinical trials in record time. Three companies driving this change and reaping its benefits are Evotec, NetraMark Holdings, and BioNTech.
Read
Commented by Fabian Lorenz on August 26th, 2025 | 07:05 CEST
The defense industry in an Industrial Revolution! Rheinmetall, RENK, and Almonty Industries are benefiting!
The defense industry is at the beginning of a supercycle. This will not change even if peace is achieved in Ukraine, which is hardly more likely after the recent summit. After years of limited capacity, often small-scale production, and difficult financing conditions, the industry is increasingly moving into a new dimension of industrialization. To rapidly rearm Europe, the focus is shifting toward standardized products, larger quantities, and efficiency along the value chain. RENK and Rheinmetall are already following this path. But of course, suppliers must also keep pace. The fact that more tungsten will soon be available outside China is likely to be a blessing for Western defense companies. Almonty has built a state-of-the-art new mine in South Korea. Analysts expect massive increases in revenue and profits.
Read
Commented by Nico Popp on August 26th, 2025 | 07:00 CEST
Two-tier market for raw materials: BHP Group, Power Metallic Mines, BYD
The term "commodity" refers to a standardized, interchangeable product with no unique characteristics. However, this principle is beginning to falter. On the one hand, production conditions are becoming increasingly important for raw materials; on the other, in an era of conflicting power blocs, tariffs, and other trade barriers, raw materials are far from interchangeable. The further processing of raw materials also gives companies in the sector the opportunity to set themselves apart from the competition and generate unique selling points. Commodity? That was yesterday! We explain the current development using the examples of BHP Group, Power Metallic Mines, and BYD, and highlight the opportunities for investors.
Read